Literature DB >> 20103358

Percutaneous extracorporeal membrane oxygenation for cardiogenic shock due to acute fulminant myocarditis.

Abdallah Fayssoil1, Olivier Nardi, David Orlikowski, Alain Combes, Jean Chastre, Djillali Annane.   

Abstract

Percutaneous extracorporeal membrane oxygenation is an invasive technique that provides emergent circulatory support for patients with cardiogenic shock. We report a favorable outcome of an acute fulminant myocarditis in a 25-year-old myasthenia patient with cardiogenic shock supported by percutaneous extracorporeal membrane oxygenation. 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20103358     DOI： 10.1016/j.athoracsur.2009.07.047

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  2 in total

1.  Position paper for the organization of ECMO programs for cardiac failure in adults.

Authors:  Darryl Abrams; A Reshad Garan; Akram Abdelbary; Matthew Bacchetta; Robert H Bartlett; James Beck; Jan Belohlavek; Yih-Sharng Chen; Eddy Fan; Niall D Ferguson; Jo-Anne Fowles; John Fraser; Michelle Gong; Ibrahim F Hassan; Carol Hodgson; Xiaotong Hou; Katarzyna Hryniewicz; Shingo Ichiba; William A Jakobleff; Roberto Lorusso; Graeme MacLaren; Shay McGuinness; Thomas Mueller; Pauline K Park; Giles Peek; Vin Pellegrino; Susanna Price; Erika B Rosenzweig; Tetsuya Sakamoto; Leonardo Salazar; Matthieu Schmidt; Arthur S Slutsky; Christian Spaulding; Hiroo Takayama; Koji Takeda; Alain Vuylsteke; Alain Combes; Daniel Brodie
Journal:  Intensive Care Med       Date:  2018-02-15       Impact factor: 17.440

2.  Associations with the In-Hospital Survival Following Extracorporeal Membrane Oxygenation in Adult Acute Fulminant Myocarditis.

Authors:  Shaur-Zheng Chong; Chih-Yuan Fang; Hsiu-Yu Fang; Huang-Chung Chen; Chien-Jen Chen; Cheng-Hsu Yang; Chi-Ling Hang; Hon-Kan Yip; Chiung-Jen Wu; Wei-Chieh Lee
Journal:  J Clin Med       Date:  2018-11-20       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.